Skip to main content
SpringerLink
Log in

Polymyalgia Rheumatica

  • Chapter
  • First Online:
Rheumatic Disease in Geriatrics

  • 534 Accesses

Abstract

Polymyalgia rheumatica (PMR) is one of the most common inflammatory rheumatologic condition occurring in older adults. It is characterized by proximal pain and stiffness in the shoulders, neck, and/or pelvic girdles in individuals over 50 years of age along with increased markers of inflammation. Although the above clinical symptoms are very characteristic for the condition, it is considered a diagnosis of exclusion as other autoimmune, as well as infectious, malignant and endocrine disorders can present with similar symptoms. It can co-occur with elderly-onset RA (EORA) or giant cell arteritis (GCA), and these should be explored as alternative diagnoses in every patient. The cornerstone of PMR treatment is low to medium doses of glucocorticosteroids (GC), but while there is typically a swift response to GC treatment, response rate is variable and flare-ups occurs in 50% of patients while tapering down GC doses. Because GC treatment itself is associated with a myriad of deleterious side effects, screening and management of patient comorbidities which may be affected by GC treatment should be carried out on a regular basis during treatment, with novel immunosuppressive agents such as interleukin (IL)-6 blocking agents being developed as GC-sparing agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Barber HS. Myalgic syndrome with constitutional effects; polymyalgia rheumatica. Ann Rheum Dis. 1957;16(2):230–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Michet CJ, Matteson EL. Polymyalgia rheumatica. BMJ. 2008;336(7647):765–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(3):633–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Matteson EL, Dejaco C. Polymyalgia rheumatica. Ann Intern Med. 2017;166(9):ITC65–80.

    Article  PubMed  Google Scholar 

  5. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. 2017;56(4):506–15.

    CAS  PubMed  Google Scholar 

  6. Dejaco C, Duftner C, Schirmer M. Are regulatory T-cells linked with aging? Exp Gerontol. 2006;41(4):339–45.

    Article  CAS  PubMed  Google Scholar 

  7. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.

    Article  CAS  PubMed  Google Scholar 

  8. Mohan SV, Liao YJ, Kim JW, Goronzy JJ, Weyand CM. Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther. 2011;13(4):231.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Stone JH, Klearman M, Collinson N. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(15):1494–5.

    PubMed  Google Scholar 

  10. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123(3):192–4.

    Article  CAS  PubMed  Google Scholar 

  11. England BR, Mikuls TR, Xie F, Yang S, Chen L, Curtis JR. Herpes zoster as a risk factor for incident giant cell arteritis. Arthritis Rheumatol. 2017;69(12):2351–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Castañeda S, García-Castañeda N, Prieto-Peña D, Martínez-Quintanilla D, Vicente EF, Blanco R, et al. Treatment of polymyalgia rheumatica. Biochem Pharmacol. 2019;165:221–9.

    Article  PubMed  CAS  Google Scholar 

  13. Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5(3):205–15.

    CAS  PubMed  Google Scholar 

  14. Caylor TL, Perkins A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. Am Fam Physician. 2013;88(10):676–84.

    PubMed  Google Scholar 

  15. Patil P, Dasgupta B. Polymyalgia rheumatica in older adults. Aging Health. 2013;9(5):483–95.

    Article  CAS  Google Scholar 

  16. Ceccato F, Uña C, Regidor M, Rillo O, Babini S, Paira S. [Conditions mimicking polymyalgia rheumatica]. Reumatol Clin. 2011;7(3):156–60.

    Article  Google Scholar 

  17. Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67(10):2569–80.

    Article  PubMed  Google Scholar 

  18. Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–92.

    Article  PubMed  Google Scholar 

  19. Slobodin G, Rimar D, Boulman N, Kaly L, Rozenbaum M, Rosner I, et al. Acute sacroiliitis. Clin Rheumatol. 2016;35(4):851–6.

    Article  PubMed  Google Scholar 

  20. Gazitt T, Kibari A, Nasrallah N, Abu Elhija M, Zisman D. Polymyalgia rheumatica: the great imitator. Isr Med Assoc J. 2019;21(9):627–8.

    PubMed  Google Scholar 

  21. González-Gay MA, García-Porrúa C, Salvarani C, Olivieri I, Hunder GG. Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Rheumatol Clin. 2011;18(6):755–9.

    Google Scholar 

  22. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33(5):289–93.

    Article  PubMed  Google Scholar 

  23. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology. 2007;46(4):672–7.

    Article  CAS  PubMed  Google Scholar 

  24. Schmidt WA, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology. 2002;41(1):46–52.

    Article  CAS  PubMed  Google Scholar 

  25. Salvarani C, Cantini F, Hunder G. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234–45.

    Article  PubMed  Google Scholar 

  26. McCarty DJ, O’Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985;254(19):2763–7.

    Article  CAS  PubMed  Google Scholar 

  27. Varshney AN, Singh NK. Syndrome of remitting seronegative symmetrical synovitis with pitting edema: a case series. J Postgrad Med. 2015;61(1):38–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Belloli L, Massarotti M, Marasini B. Polymyalgia rheumatica and elderly onset rheumatoid arthritis. J Clin Rheumatol. 2008;14(1):59.

    Article  PubMed  Google Scholar 

  29. Goldstein BL, Gedmintas L, Todd DJ. Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4. Arthritis Rheumatol. 2014;66(3):768–9.

    Article  PubMed  Google Scholar 

  30. Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B, Leary A, Voisin AL, Pontoizeau C, Coutte L, Pertuiset E, Mouterde G, Fain O, Lambotte O, Mariette X. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Ann Rheum Dis. 2017;76(10):1747–50.

    Article  CAS  PubMed  Google Scholar 

  31. Garel B, Kramkimel N, Trouvin A-P, Frantz C, Dupin N. Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma. Joint Bone Spine. 2017;84(2):233–4.

    Article  PubMed  Google Scholar 

  32. Calabrese C, Cappelli LC, Kostine M, Kirchner E, Braaten T, Calabrese L. Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature. RMD Open. 2019;5(1):e000906.

    Article  PubMed  PubMed Central  Google Scholar 

  33. van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414–22.

    Article  PubMed  CAS  Google Scholar 

  34. Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology. 2010;49(1):186–90.

    Article  PubMed  Google Scholar 

  35. Hernández-Rodríguez J, Cid MC, López-Soto A, Espigol-Frigolé G, Bosch X. Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med. 2009;169(20):1839–50.

    Article  PubMed  Google Scholar 

  36. Dasgupta B, Dolan AL, Panayi GS, Fernandes L. An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol. 1998;37(2):189–95.

    Article  CAS  PubMed  Google Scholar 

  37. Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol. 1996;23(4):624–8.

    CAS  PubMed  Google Scholar 

  38. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004;141(7):493–500.

    Article  CAS  PubMed  Google Scholar 

  39. De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis. 1986;45(2):136–8.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Adizie T, Christidis D, Dharmapaliah C, Borg F, Dasgupta B. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series. Int J Clin Pract. 2012;66(9):906–9.

    Article  CAS  PubMed  Google Scholar 

  41. Diamantopoulos AP, Hetland H, Myklebust G. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series. Biomed Res Int. 2013;2013:120638.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Lally L, Forbess L, Hatzis C, Spiera R. Brief report: a prospective open-label phase IIa trial of tocilizumab in the treatment of polymyalgia rheumatica. Arthritis Rheumatol. 2016;68(10):2550–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, et al. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study. Ann Rheum Dis. 2016;75(8):1506–10.

    Article  CAS  PubMed  Google Scholar 

  44. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, et al. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011;70(3):447–53.

    Article  PubMed  Google Scholar 

  45. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672–80.

    Article  CAS  PubMed  Google Scholar 

  46. Gabriel SE, Sunku J, Salvarani C, O’Fallon WM, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997;40(10):1873–8.

    Article  CAS  PubMed  Google Scholar 

  47. Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521–37.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Unit, Carmel Medical Center, Haifa, Israel

    Tal Gazitt & Devy Zisman

  2. The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

    Devy Zisman

Authors
  1. Tal Gazitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devy Zisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Devy Zisman .

Editor information

Editors and Affiliations

  1. Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel

    Gleb Slobodin

  2. Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel

    Yehuda Shoenfeld

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gazitt, T., Zisman, D. (2020). Polymyalgia Rheumatica. In: Slobodin, G., Shoenfeld, Y. (eds) Rheumatic Disease in Geriatrics . Springer, Cham. https://doi.org/10.1007/978-3-030-44234-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44234-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-44233-0

  • Online ISBN: 978-3-030-44234-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation